Delivery Order SPE2DB20D1109-SPE2DB25FP63G
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for Ciprofloxacin-Dexamethasone Otic Suspension 7.5ML, with a ceiling value of $1,272.60 and completion deadline of August 14, 2025. This firm fixed-price, competitively awarded delivery order represents a continuation of AmerisourceBergen's established role as a critical pharmaceutical supplier to the Department of Defense. The contract carries no set-aside designation...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension 7.5ml, with a ceiling value of $1,692.67. This is a firm fixed-price delivery order with no set-aside designation, performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania, and is scheduled for completion by August 15, 2025. The award represents a small-value pharmaceutical procurement typical of the...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension in 7.5mL units, with a ceiling value of $5,780.82. This non-set-aside, competitively awarded contract utilizes firm fixed price pricing and is scheduled for completion by July 29, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,780.32 to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension (7.5ML) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension 7.5mL, valued at $3,876.32. This firm fixed-price delivery order, which is not a set-aside contract, represents a competitively awarded transaction under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's corporate...
- The Defense Logistics Agency awarded a $1,089.54 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension in 7.5mL units. This firm fixed-price delivery order, which is non-set-aside and competitively awarded, is scheduled for ultimate completion on August 13, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension in 7.5ml quantities, with a ceiling value of $9,283.58 and a completion date of July 30, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded through open procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $1,569.12 firm fixed-price delivery order on August 28, 2025, for Ciprofloxacin-Dexamethasone otic suspension in 7.5ml units, with completion scheduled for August 29, 2025. This delivery order, which carries no set-aside designation, represents a competitively awarded transaction under the company's larger contract vehicle with DLA. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order contract valued at $2,288.30 to AmerisourceBergen Drug Corp for the supply of Ciprofloxacin-Dexamethasone Otic Suspension 7.5ML, a combination antibiotic and anti-inflammatory medication used for ear infections. This competitively awarded, firm fixed-price delivery order was issued on August 20, 2025, with an ultimate completion date of August 21, 2025. The product will be delivered to the Conshohocken, Pennsylvania location, which serves...
- The Defense Logistics Agency awarded a $1,670.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension in 7.5 mL quantities. This is an unset-aside, competitively awarded contract with an ultimate completion date of July 22, 2025. The delivery order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP63GDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension 7.5mL with a ceiling value of $3,041.15. The contract is a firm fixed price delivery order with an ultimate completion date of August 26, 2025, and represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999 through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp regularly supplies a broad range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The Ciprofloxacin-Dexamethasone combination represents a standard ophthalmic/otic antibiotic-corticosteroid product commonly used in military and federal healthcare settings for infection and inflammation management.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 8/25/25 |